相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Heart Disease and Stroke Statistics-2019 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2019)
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Craig T. January et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation
Hsin-Fu Lee et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Anticoagulation for Atrial Fibrillation in Cirrhosis of the Liver: Are Low-Dose Non-Vitamin K Oral Anticoagulants a Reasonable Alternative to Warfarin?
Celine Gallagher et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease
So-Ryoung Lee et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Oral Anticoagulants in Liver Disease Not Child's Play
Elaine M. Hylek et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease
Arman Qamar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Efficacy and safety of anticoagulation for atrial fibrillation in patients with cirrhosis: A systematic review and meta-analysis
Ronpichai Chokesuwattanaskul et al.
DIGESTIVE AND LIVER DISEASE (2019)
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Jan Steffel et al.
EUROPEAN HEART JOURNAL (2018)
Safety of direct oral anticoagulants vs warfarin in patients with chronic liver disease and atrial fibrillation
Pavel Goriacko et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2018)
Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants
Daniele Pastori et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Oral Anticoagulation in Patients With Liver Disease
Arman Qamar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Direct oral anticoagulants in patients with liver cirrhosis: A systematic review
Evert Willian Hoolwerf et al.
THROMBOSIS RESEARCH (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants
Daniele Pastori et al.
DATA IN BRIEF (2018)
Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?
Ling Kuo et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paulus Kirchhof et al.
EUROPEAN HEART JOURNAL (2016)
Advances in the meta-analysis of heterogeneous clinical trials II: The quality effects model
Suhail A. R. Doi et al.
CONTEMPORARY CLINICAL TRIALS (2015)
The Role of Macrolide Antibiotics in Increasing Cardiovascular Risk
Yun-Jiu Cheng et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society
Craig T. January et al.
CIRCULATION (2014)
Stratifying the Risks of Oral Anticoagulation in Patients With Liver Disease
Lydia M. Efird et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2014)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials
Benjamin D. Fox et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
MECHANISMS OF DISEASE The Coagulopathy of Chronic Liver Disease
Armando Tripodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Hypercoagulation in Liver Disease
Patrick G. Northup
CLINICS IN LIVER DISEASE (2009)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease
A. Tripodi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
分享论文
